Aragen Bioscience, Inc. Awarded Three Preclinical Development NIAID Subcontracts
4/5/2011 8:41:47 AM
MORGAN HILL, Calif.--(BUSINESS WIRE)--Aragen Bioscience, Inc., today announced it is a subcontractor on a National Institute of Allergy and Infectious Diseases (NIAID) contract for the preclinical development of monoclonal antibodies for the prevention and treatment of infectious diseases.
comments powered by